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Serving a robust platform for reverse genetics enabling the in vivo study of
gene functions primarily in enterobacteriaceae, recombineering -or recombination-
mediated genetic engineering-represents a powerful and relative straightforward genetic
engineering tool. Catalyzed by components of bacteriophage-encoded homologous
recombination systems and only requiring short ∼40–50 base homologies, the targeted
and precise introduction of modifications (e.g., deletions, knockouts, insertions and
point mutations) into the chromosome and other episomal replicons is empowered.
Furthermore, by its ability to make use of both double- and single-stranded linear
DNA editing substrates (e.g., PCR products or oligonucleotides, respectively), lengthy
subcloning of specific DNA sequences is circumvented. Further, the more recent
implementation of CRISPR-associated endonucleases has allowed for more efficient
screening of successful recombinants by the selective purging of non-edited cells, as
well as the creation of markerless and scarless mutants. In this review we discuss
various recombineering strategies to promote different types of gene modifications, how
they are best applied, and their possible pitfalls.
Keywords: bacterial genetics, enterobacteriaceae, (phage-based) homologous recombination, precise genome
editing, recombineering, reverse genetics, selection markers
INTRODUCTION
With the advent of next-generation sequencing, there has been an exponential rise in the number of
complete bacterial genome sequences that were made publicly available (Land et al., 2015), making
it necessary to increase efforts to correctly annotate and assign gene functions. The latter task
is mostly achieved by reverse genetic approaches that consist of altering the gene sequence e.g.,
deletion, tagging, reporter gene fusion or by introducing base pair (bp) changes, to determine its
function by phenotypic analysis. Genome editing of bacteria is typically attained by homologous
recombination between the target gene and an editing substrate that can either be circular or
linear DNA, the latter being single-stranded DNA (ssDNA) oligonucleotides (oligos) or double-
stranded PCR products (dsDNA). These editing substrates are introduced in the bacteria using
transformation, conjugation or transduction, and we refer to Snyder et al. (2013) for more detailed
information on these different strategies. Homologous recombination between the target gene and
the editing substrate can be achieved by endogenously expressed recombination genes (e.g., allelic
exchange by cointegrate formation and resolution), the use of recombination-proficient strains,
or alternatively, by phage recombination systems (i.e., recombineering). Particularly, the use of
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phage recombineering proteins to perform recombineering
was proven to be a highly efficient method to modify not
only bacterial chromosomes, but also other replicons such as
bacterial artificial chromosomes (BACs), which are frequently
used to accommodate large inserts [up to several hundred kilo
base pairs (kbp)]. In particular, Escherichia coli (E. coli) and
Salmonella enterica (S. enterica) have extensively been used as
workhorses for the implementation and development of different
DNA-based recombineering technologies (Cronan, 2014). While
recombineering strategies will be the main focus of this review,
bacterial gene replacements historically involved allelic exchange
methodologies, and thus will also be briefly discussed. Such
approaches still remain critical for modifying bacteria where
phage recombination systems are not yet available, or where
DNA transformation protocols are inefficient. While previous
excellent reviews on this topic have been published (Court et al.,
2002; Thomason et al., 2007, 2014; Murphy, 2016), we here focus
on the applicability of recombineering for reverse genetics, and
discuss the most recent developments in the field of bacterial
recombineering. A flowchart of the strategies highlighted in our
review is provided in Figure 1.
SELECTION AND COUNTER-SELECTION
RECOMBINEERING STRATEGIES
The very first and common step of most genome engineering
strategies is the introduction of exogenous DNA elements
(e.g., plasmids, dsDNA or ssDNA), which is often achieved
by transformation. While transformation is typically more
convenient than other strategies (e.g., conjugation for large-scale
studies), in the case of commonly used electrical transformation
(i.e., electroporation), only up to 5% of input cells are
transformed when making use of plasmid DNA (Wu et al., 2010).
Moreover, exact efficiencies of transformation are very difficult to
report since they depend on many variables such as residual salt
or charged chemicals prior to electroporation, the number and
density of electroporated cells, electroporation volume, survivors
of electroporation, type and input of DNA and the growth phase
among others (Wu et al., 2010).
Besides considering efficiencies at the individual steps of a
recombination strategy, there is an inherent efficiency limitation.
As discussed in Pines et al. (2015), the theoretical maximum
recombination efficiency in bacteria is mainly determined by
bacterial chromosome segregation during cell division, requiring
up to two replication rounds for complete segregation of
the introduced modification to one of four daughter cells.
Furthermore, exponentially growing bacteria normally contain
up to 8 copies of their chromosome, which decreases this
efficiency even further. Taken together, when considering that
5% of input cells are transformed and that only 3–6% of these
will contain the desired modification, the maximum efficiency of
recombination is only∼0.15–0.3%. Therefore, to avoid extensive
and time-consuming screening of transformed bacteria in an
exceedingly non-edited background, co-transformation with
different drug resistance (drugR) markers is frequently used to
select for transformed bacteria. These markers can be classified as
positive selectable, when upon selection they confer an advantage
to the transformants over non-edited cells, or as negative (or
counter-selectable) when they eliminate or inhibit growth of the
transformed cell. Some commonly used gene markers and their
genetic background compatibility are summarized in Table 1.
Phenotypic screening markers can be used as an alternative to
drugR selectable markers. Expression of chromoproteins such as
amilCP or magenta tsPurple results in blue and purple colonies
respectively, enabling selection by colony coloring (Lazarus et al.,
2019). While a palette of engineered chromoproteins was recently
assessed in E. coli, it is noteworthy that optimal conditions for
attaining intense coloring, low fitness cost, and fast maturation
have not yet been described (Liljeruhm et al., 2018). In the
context of recombineering editing substrates, the alpha subunit
from lacZ (lacZ’) has been used to restore the LacZ + phenotype
when delivered into LacZ− cells (lacZ1M15, Yanisch-Perron
et al., 1985) known as alpha complementation (Ullmann et al.,
1967). Using this assay, visual inspection of colonies on LB agar
plates supplemented with X-Gal substrate allow differentiation of
blue transformed colonies from white non-transformed colonies,
which are unable to metabolize X-Gal (Pyne et al., 2015).
Other reporter genes that can be used to identify transformants,
are green fluorescence protein (GFP), DsRed and luciferase
(Gerlach et al., 2007).
Several markers are appropriate for positive selection
of transformants, the most widely used being antibiotic
resistance markers, mostly because selection is easily achieved
by supplementing the media with the desired antibiotic. Some
bacterial antibiotic selection markers that have been used
extensively are genes conferring resistance to kanamycin (kan
gene), chloramphenicol (cat gene), ampicillin (bla gene, beta-
lactamase) and tetracycline (tetR and tetA genes) (Table 1).
Another strategy uses tolC, encoding the outer membrane protein
TolC that harbors efflux transmembrane transporter activity,
which confers an increased resistance to toxic molecules such as
sodium dodecyl sulfate (SDS), while its loss confers resistance
to the membrane depolarization activity of colicin E1, allowing
for its direct counter-selection (DeVito, 2008). Another example
is tetA, the removal of which can also be counter-selected with
fusaric acid or NiCl2, as these compounds are selectively lethal
to cells expressing tetA (Maloy and Nunn, 1981; Podolsky et al.,
1996). Some genes are only counter-selectable and thus do not
require a particular genetic background, e.g., Bacillus subtilis
sacB, and have therefore been frequently used in combination
with a positive selectable marker (Li et al., 2013). Of note,
a limitation of sacB counter-selection is acquired bacterial
resistance to its toxic product given the high spontaneous
sacB+ to sacB− conversion rate observed (10−4) (Hmelo et al.,
2015). Another example of counter-selection is the use of the
bactericidal phage gene kil under the control of a temperature-
sensitive repressor cI857. Shifting the temperature to 42◦C
results in repressor inactivation and concomitantly, killing of
bacteria expressing kil (Chen et al., 2020). The A294G mutant
of E. coli phenylalanyl-tRNA synthetase (pheSGly294) is another
counter-selection marker that can be used, as the mutant PheS
permits 4-chloro-phenylalanine incorporation in proteins, which
is toxic for cells (Li and Elledge, 2005). The use of the ccdB
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FIGURE 1 | Flowchart of genetic engineering strategies. Schematic representation of different strategies (filled green boxes) categorized by their overall aim (filled red
boxes), editing substrates to be used (red boxes), (counter) selection (red dashed line), screening (green dashed line) and efficiencies of attaining successful
transformants (green boxes). N.A, not applicable; bp, base pair; kbp, kilo base pair; dsDNA, double stranded DNA; ssDNA, single stranded DNA; DSB, double
strand break.
toxin/ccdA antitoxin system constitutes an efficient counter-
selection strategy for the selection of recombinant cells by
insertion of the ccdB-bla cassette (media supplemented with
ampicillin) while expressing antitoxin ccdA from a temperature-
sensitive Red-producing plasmid. Switching to non-permissive
temperatures (42◦C) results in the loss of ccdA encoding plasmid
and only cells that successfully exchanged the ccdB cassette by
a second recombineering event survive (Wang H. et al., 2014;
Zhang et al., 2017).
Incorporation of so-called metabolic markers (Table 1)
enables transformants to grow in the presence of different carbon
sources or in media lacking an otherwise essential nutrient.
However, the use of metabolic markers requires, besides an
appropriate genetic background, the use of defined or minimal
media in which bacteria often grow poorly (Li et al., 2014). An
example of a metabolic marker is galK, as galK transformants
can be selected by growing with galactose as the unique
carbon source. Counter-selection with galK is performed in
media supplemented with 2-deoxy-galactose (DOG), as upon
phosphorylation of DOG by GalK, the toxic compound 2-deoxy-
galactose-1-phosphate is produced (Alper and Ames, 1975).
Another commonly used metabolic marker thyA, encodes the
enzyme thymidylate synthase (ThyA) transformants of which can
be selected for in media lacking the essential nutrient thiamine
and counter-selected with trimethoprim, the latter acting as an
inhibitor of dihydrofolate (DHF) reductase (Stacey and Simson,
1965; Stringer et al., 2012). DHF is responsible for replenishing
the levels of tetrahydrofolate (THF), an essential cofactor for
many cellular processes, including ThyA functioning. Those cells
containing thyA rapidly consume the pool of THF, and ensuing
growth is suppressed due to incapability to replenish THF. On
the contrary, in cells without thyA, the THF pool is maintained
for other cellular reactions, and thus the absence of thyA can be
selected for on minimal media plates containing both thiamine
and trimethoprim (Wong et al., 2005). Clearly, the use of galK
and thyA as both selection and counter-selection markers is
restricted to strains that do not encode functional copies of these
genes on their chromosomes. As such, the use of both thyA
and galK as markers have most commonly been applied for the
manipulation of plasmids and bacterial artificial chromosomes
(BAC), where transformation of these episomes into E. coli must
be performed as a first step. The use of thyA or galK strains



















TABLE 1 | Commonly used gene markers for selection and/or counter-selection of modified over non-edited bacteria.




(Original) gene source Strain genetic
background
Commonly used antibiotic resistance cassettes
neoR, kan, nptII Neomycin
phosphotransferase II





Chloramphenicol N.A. Escherichia coli (Shaw et al., 1979) N.A
bla Beta-lactamase Ampicillin N.A. Escherichia coli (Ambler and Scott, 1978) N.A
tetR Tetracycline repressor
protein class C
Tetracycline Fusaric acid or NiCl2 Escherichia coli (Podolsky et al., 1996;




Tetracycline Fusaric acid or NiCl2 Escherichia coli (Maloy and Nunn, 1981;
Podolsky et al., 1996)
N.A
Metabolic markers
galK Galactokinase Minimal media with
galactose as unique carbon
source
2-deoxy-galactose (DOG) Alper and Ames, 1975 1galK
thyA Thymidylate synthase Media lacking thiamine Trimethoprim Stacey and Simson, 1965 1thyA
pyrE Phosphoribosyl transferase Media lacking uracil 5-fluoroorotic acid (5-FOA) Sakaguchi et al., 2013 1pyrE
pyrF Decarboxylase Media lacking uracil 5-fluoroorotic acid (5-FOA) Galvao and de Lorenzo, 2005 1pyrF
upp Phosphoribosyl transferase Media lacking uracil 5-fluoroorotic acid (5-FOA) Fabret et al., 2002 1upp
Other markers




Colicin E1 DeVito, 2008 1tolC
sacB Levansucrase N.A. Sucrose Bacillus subtilis (Gay et al., 1985) N.A
kil, repressor cI857 Kil 30◦C (cI857 active) 42◦C (cI857 inactive) Bacteriophage lambda (Chen et al., 2020) N.A
pheS Gly204 Mutant tRNA synthetase N.A Chloro-phenylalanine Li and Elledge, 2005 N.A
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(in place of wild type E. coli) thus does not require an additional
step for making genetic manipulations of episomes (Warming
et al., 2005; Wong et al., 2005).
In this context, it is however noteworthy that, while a 1thyA
strain – promoted as a standard strain for permitting a more
versatile and efficient recombination in enterobacteria (Stringer
et al., 2012) – was successfully created in the S. enterica strain
14028s (Stringer et al., 2012), we and others were unable to
attain a 1thyA deletion mutant in the context of S. enterica
strain SL1344 (personal communication Prof. Joseph Wade
(Wadsworth Center, New York, United States of America)
and our unpublished observation), which likely indicated its
essentiality in this specific S. enterica strain, as thyA was reported
among the 343 essential SL1344 genes when grown in rich
medium (Barquist et al., 2013). Other metabolic markers broadly
used in bacteria (Fabret et al., 2002; Galvao and de Lorenzo,
2005; Sakaguchi et al., 2013) include E. coli pyrE and pyrF or
the B. subtilis pyrE ortholog upp, all implicated in the pathway
of pyrimidine synthesis and counter-selectable in strains with
the corresponding genetic background (e.g., 1pyrE, 1pyrF or
1upp). Bacteria harboring a copy of any of these markers are
able to grow in the absence of uracil and are sensitive to 5-
fluoroorotic acid (5-FOA) given its metabolization to the highly
toxic compound 5-fluorouridine monophosphate (5-FMP).
GENE INSERTION, DELETION OR
MUTATION VIA ENDOGENOUS
RECOMBINATION SYSTEMS
Gene editing by homologous recombination involves the
exchange between homologs DNA sequences in a process
catalyzed by recombination systems, each characterized by
its minimal length of DNA homology required. Homologous
recombination is a complex process, where the DNA exchange
mechanisms consist of early, intermediate and late phases. While
the early phase consists of the end-processing and invasion of
ssDNA from one DNA duplex into another to form a D-loop,
the intermediate phase consists of the formation of branched
DNA that eventually form recombination intermediates know
as Holliday junctions. In the final phase, the Holliday junctions
are cut by resolvases to generate recombinant chromosomes,
either with or without crossover of flanking sequences (Figure 2).
Different resolution cuts at the left or the right of the junctions
result in four possible outcomes: two recombinant molecules
with exchange of flanking sequences, or two patch recombinants
with no exchange of flanking sequences. Note that while there
are several types of branched DNA molecules, for the sake of
simplicity double Holliday junctions are shown in Figure 2. For
details on resolution mechanisms we refer to Kuzminov (2011).
A suicide plasmid cannot replicate under certain conditions
(e.g., host incompatibility, non-permissive temperatures), and
thus only its integration into the chromosome by homologous
recombination prevents its loss. This mechanism of integration
depends on endogenous homologous recombination systems and
is the first event leading to a classical mechanism of allelic
exchange. Its application greatly facilitated chromosomal gene
replacement and the generation of knockouts, and is of central
importance for reverse genetic-assisted discoveries in many
Gram-negative bacteria. This strategy was first established in
1989 by Hamilton et al. (1989), who reported the use of a
plasmid with a thermosensitive conditional replication origin and
antibiotic resistance cassette to replace a gene with a mutated
allele. Transformed bacteria that inserted the plasmid DNA
sequence into their chromosome, known as co-integrants or
merodiploids, were formed at non-permissive temperatures by
homologous recombination between the chromosomal wild-
type gene and the mutated gene cloned in the suicide
plasmid, a process referred to as recombination in trans. After
selection of antibiotics-resistant co-integrants, a second in cis
or intrachromosomal recombination event – between the two
duplicated copies of the gene (wild-type and mutated) – can
occur at permissive temperatures, leading to the resolution
of the co-integrant, an event which can be selected by the
screening for sensitivity to the antibiotic used in the selection of
the co-integrant.
An improved version of this strategy (Link et al., 1997)
identified the resolution of recombinants using sacB counter-
selection by the killing of non-resolved co-integrants upon
sucrose addition. Besides allelic replacement, gene insertions
and deletions can be generated using this strategy (Lee et al.,
2007; Winkler and Kao, 2012; Sahu et al., 2013). Of note, in
difficult-to-transform bacterial strains (e.g., Serratia marcescens),
conjugation constitutes an alternative approach to introduce the
plasmid DNA editing substrates (Snyder et al., 2013). Here,
the plasmid DNA is transferred from a donor strain to a
recipient strain in a process dependent on a pilus structure
(Lazarus et al., 2019).
The main drawback of the use of allelic exchange approaches
is the need to perform extensive screening (e.g., colony PCR,
sequencing or phenotypic testing) to select those transformants
that resulted in the resolution outcome that contains the desired
change in the chromosome (i.e., did not re-generate the wild-type
genetic sequence), making it an inefficient and time-consuming
procedure. Furthermore, endogenous host cell recombination
systems require large homology arms (see below), which also
make the often tedious sub-cloning and construction of lengthy
editing sequences in appropriate vectors a prerequisite.
RECOMBINEERING: GENETIC EDITING
BY MEANS OF PHAGE RECOMBINATION
FUNCTIONS
Since allelic exchange makes use of dsDNA allelic exchange
substrates, cloning using linear DNA substrates is more
straightforward as it requires fewer DNA manipulations and the
introduction of the homologous substrate is usually provided
in the form of PCR products or synthetic oligos. However, as
part of the bacterial defense system, bacterial transformation
with linear DNA typically results in DNA degradation by
endogenous nucleases. More specifically, while bacterial DNA
is protected from nuclease action by sequence-specific DNA
methylation introduced by the action of DNA methyltransferases
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FIGURE 2 | General scheme of homologous recombination. Early, intermediate and late phases of homologous recombination: in the early phase the ssDNA arm
from a nicked chromosome invades a homologous chromosome forming a D-loop, the resulting branched DNA leads to the formation of a double Holliday Junction
intermediate. Holliday junctions can be resolved during the late phase by two types of resolution cuts, designated 1 and 2, resulting in different recombination
outcomes. Resolution of Holliday junctions by the same cuts (i.e., 1–1 or 2–2) results in recombinants molecules, while resolution of Holliday junctions by the different
cuts (i.e., 1–2 or 2–1) results in wild-type molecules with parental shoulders. Figure adapted from Kuzminov (2011).
(Marinus and Løbner-Olesen, 2014), non-methylated incoming
linear exogenous DNA is cut by bacterial nucleases.
Besides their role in bacterial defense systems and common
use for the purpose of molecular cloning (e.g., EcoRI and
BamHI), exo- and endonucleases are also crucial for DNA repair
and recombination functions. In view of the later, removal of
restriction systems was shown to be important for getting good
recombination efficiency (Mosberg et al., 2012) and scientists
struggled for many years to knock-out the important restriction
systems to “domesticate” their favorite organism. For example,
the domesticated MG1655 derived DH5α E. coli strain contains
inactivating mutations in the endonuclease genes endA and
hsdR17, thereby facilitating cloning and recombineering, next to
improving plasmid yield (Woodcock et al., 1989; Chen et al.,
2018). As nuclease activity and recombineering efficiency are
thus heavily intertwined, we refer to Lovett (2011) for a more
extensive description on the function and characterization of
nucleases involved.
With its high affinity toward dsDNA ends (Taylor and Smith,
1985; Roman and Kowalczykowski, 1989), the RecBCD nuclease
was shown to be the main actor in degrading linear exogenous
DNA. RecBCD, formed by RecB, RecC, and RecD possesses DNA
helicase and exo- and endonuclease activity, and plays a role
in recA mediated recombination, a process mainly implicated
in DNA damage repair. Historically, one strategy to promote
recombination with linear DNA was the use of a recombination-
proficient strain carrying null mutations of the recB (recB22)
and recC (recC21) genes; these mutants lacked nuclease activity
and were deficient in recombination. By selection of suppressor
mutations in recB22 recC21 strains that restored recombination
proficiency, it was found that inactivation of the sbcBC
genes (suppressor of recBC mutations) activated an alternative
recombination pathway that was dependent on RecF activity,
and became known as the RecF pathway (Kushner et al., 1971;
Lloyd and Buckman, 1985). Later on, it was discovered that
uniquely mutating recD resulted in the creation of a nuclease-
deficient recombination-proficient strain (Russell et al., 1989).
However, the use of this mutated strain often led to unwanted
recombination events and subsequent genome instability.
However, the advent of phage recombineering systems not
only greatly improved recombination efficiencies and reduced
homology length requirements, but additionally permitted
the expression of recombineering proteins from inducible
promotors, thereby avoiding genome instability (see below).
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FIGURE 3 | Tagging of the chromosomal rplL gene in Salmonella enterica strain SL1344 and FLP-mediated excision of the antibiotics resistance cassette. The
resistance marker kan, flanked by FRT regions, is PCR-amplified from the plasmid pKD4 by making use of primers P1 and P2, with rplL C-terminus and downstream
homology regions (H1 and H2), respectively. Primer P1 also contains a tag (i.e., AVI-tag) sequence followed by a translation stop codon (TAA). The resulting linear
dsDNA PCR product flanked with sequences homologous to the target region is electroporated into competent S. enterica expressing λ red recombination genes.
Upon selection of kanamycin resistant transformants, flippase (FLP) mediated kan gene excision is induced, leaving an FRT scar sequence. In line with the tagging of
E. coli rplL performed in Ederth et al. (2009), tagging of rplL of Salmonella enterica strain SL1344 was performed in house.
In 1998, the action of the recombination proteins from
the bacteriophage lambda (λ) red system were reported to
outperform the recombination efficiency of the traditionally
used 1recBCD sbcBC or recD mutant E. coli strains as up
to 130-fold when using linear products with large homology
arms as editing substrates (Murphy, 1998). Later in that
same year, the Rac prophage recombination functions RecET
were reported to promote gene replacement with homology
arms as short as 40 bp, ∼10-fold shorter as compared to
homology arms used in case of recombination performed
when making use of E. coli recombination-proficient strains
with endogenous mutated recombinases (Zhang et al., 1998).
While the homology requirements needed for recombination
in the context of phage infection are still unknown, shortening
of homology arms represented a breakthrough in genetic
engineering, as it led to the use of PCR-generated linear substrates
containing short flanking homologies as allelic exchange
substrates, thus avoiding the need for sub-cloning of long
homology arms for the construction of editing substrates. Since
their introduction, and in light of their increased performance
over endogenously-derived recombination-proficient bacterial
strains, phage recombineering systems have widely been adopted
for genome engineering in the last 20 years.
Bacteriophage λ-mediated recombineering involves
the expression of the bacteriophage λ-encoded genetic
recombination machinery, named the λ red system, consisting
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of the exo and bet genes, and assisted by the gam gene. Together,
these genes are designated λ red genes. Noteworthy, Rac
prophage recombineering genes, recE and recT found in E. coli,
encode non-homologs but functionally equivalent products as
exo and bet genes, respectively (Clark et al., 1993). The product
of the gam gene, the Gam protein, inhibits RecBCD and SbcCD
exonuclease activities (Sakaki et al., 1973; Kulkarni and Stahl,
1989; Murphy, 1991), thereby avoiding degradation of linear
exogenous DNA. Exo is a 5′3′ exonuclease which targets dsDNA
and Bet is a ssDNA-binding protein that promotes the annealing
of complementary ssDNA strands. When bound to ssDNA, Bet
protects its substrate from degradation. Exo, Bet and Gam thus
promote homologous recombination between a target gene and
a linear dsDNA PCR fragment containing a selection marker
or, alternatively, a ssDNA oligo, with both substrates containing
short homology regions to the target region.
While the molecular details of the mechanism of λ red
homologous recombination are not yet completely deciphered,
evidence so far indicates that it can occur via at least two
distinct pathways: one being recA-dependent and replication-
independent or so-called strand invasion, and one being recA-
independent and replication-dependent or so-called strand
annealing (Stahl et al., 1997; Murphy and Marinus, 2010; Poteete,
2013). In the context of recombineering, there is conclusive
evidence that λ red recombination between exogenous and
chromosomal DNA occurs at the replication fork, preferentially
through the interaction with the lagging strand template (Lim
et al., 2008). This was illustrated by Lim et al. (2008) who
inserted non-homologous regions with progressively increasing
length at the end of oligos corresponding to both the lagging
or the leading strand of the replication fork. They observed
that non-homologous sites attached to an oligo corresponding
to the lagging strand reduced the recombination efficiency ∼7-
fold. Other oligo-based studies also showed that recombination
occurs with a higher efficiency (up to ∼30-fold) via annealing of
oligos to the lagging strand template (Ellis et al., 2001; Costantino
and Court, 2003; Li et al., 2003; Sawitzke et al., 2011). Based
on these observations, the discontinuous nature of the lagging
strand appears to accommodate the efficient annealing of ssDNA
oligos to the lagging strand template better relative to the leading
strand template, presumably because of the presence of gaps in
the leading strand. For more details of λ red recombineering and
its proposed molecular mechanisms, we would like to refer to
(Murphy, 2016).
To date, three different ways of expressing λ red genes
have been reported, namely plasmid, chromosome or defective
λ prophage-based expression. All of them rely on the tightly
controlled expression of the λ red recombination genes from
strong inducible promotors (which are induced for expression by
either IPTG, arabinose or a shift in temperature). Tight control
in red expression is important to avoid undesirable secondary
mutations (and thus genome instability) as spontaneous
generation of antibiotic-resistant colonies were reported in
E. coli when constitutively expressing λ red recombination genes
(Murphy and Campellone, 2003). Moreover, due to inhibition
of RecBCD (Sergueev et al., 2001), Gam expression also infers
a certain degree of toxicity to the cells. In the case of Rac
recombineering functions, expression of recE and recT genes
from the endogenous Rac prophage only gives low levels
of recombineering, thus requiring expression from multicopy
plasmids under the control of heterologous promoters (e.g.,
the arabinose-inducible pBAD promoter; Zhang et al., 1998) to
promote efficient gene replacement.
The λ red system was first implemented by Murphy (1998),
who expressed exo, bet and gam either from a high copy
plasmid or from the chromosome. Based on the belief that
phage recombination systems require long homology lengths, the
flanking homology sequences used in this study were lengthy,
between ∼1000 and 3500 bp. Surprisingly, despite the lower
expression of the λ red system, Murphy’s work (Murphy, 1998)
indicated a 4-fold increase in the recombination frequencies
when exo, bet and gam were expressed from the chromosome, a
compensation explained by the absence of competitive plasmid
multimers which inhibit the recombination process. Later on
Datsenko and Wanner (2000) shortened the homology regions
used for recombination to 36–50 bp and expressed exo, bet
and gam from the low copy helper plasmid, pKD46. More
specifically, pKD46 contains a temperature sensitive origin of
replication, which facilitates its later curing by switching to non-
permissive temperatures. In this context, plasmid clearance was
proven essential to avoid secondary mutations such as large
random deletions (deletion up to 17 kbp were demonstrated)
(Hobman et al., 2007).
The λ red genes can also be expressed under their native
control from a defective prophage in which the operon structure
encoding the DNA replication genes, lysis cassette and structural
genes is deleted (Yu et al., 2000; Ellis et al., 2001). In strains
containing this defective prophage, e.g., DY380 (Lee et al., 2001),
exo, bet and gam genes are expressed from the endogenous pL
operon under control of cI857, which encodes a temperature-
sensitive version of the cI repressor that is only functional at low
temperatures (below 34◦C). Its inactivation is therefore possible
by shifting the temperature to 42◦C with the concomitant
expression of exo, bet and gam genes. To introduce λ red
functions in the desired strain, mini-λ (Court et al., 2003)
circular non-replicating phage DNA can be introduced into
any strain, where it is stably integrated into the chromosome
by site-specific recombination, and thus without requiring
selection for maintenance. By the introduction of an antibiotic
resistance cassette flanked by 50 bp homology regions, gene
knock-outs were achieved with an efficiency of ∼0.1% (i.e.,
up to 1 transformant per 1000 electroporated cells). A study
reporting the use of plasmids with a different origin of replication
expressing exo, bet and gam genes under their native control
(pSIM plasmids) achieved similar efficiencies of gene knock-outs
in E. coli and S. enterica as those reported for the prophage strain
(Datta et al., 2006), while up to 10 to 100- fold higher efficiencies
were reported for these strains when compared to making use
of the pKD119 plasmid (Datsenko and Wanner, 2000), a pKD46
related plasmid with a different selection marker.
The RecET recombination system was implemented for the
first time by Zhang et al. (1998), additionally requiring the
co-expression of gam from λ red to inhibit RecBCD activity.
Since RecE is ∼4-fold larger than its functional homolog Exo
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(Kovall and Matthews, 1997; Zhang et al., 2009), only its
C-terminal domain has typically been used. Nevertheless, full
length RecE (along with RecT and λ Gam) was shown to promote
recombination between linear dsDNA species at considerably
higher efficiencies than λ red recombineering (Fu et al., 2012),
making it the better alternative for incorporation of linear dsDNA
into a linear plasmid (Thomason et al., 2014).
STRATEGIES FOR REMOVAL OF
SELECTION MARKERS
In case of successful transformation, removal of selection markers
is desirable to avoid possible transcriptional perturbation due
to the presence of the marker’s promoter. This removal can be
achieved by the Saccharomyces cerevisiae flippase (FLP), a site-
specific recombinase that catalyzes excision of DNA between two
tandem FLP recombination target sequences (FRTs) (Sherman,
1982). This process is illustrated in Figure 3, where after tagging
of the rplL gene, the kanamycin selection marker is removed.
Since FLP-mediated excision requires FRT sites flanking the
selection cassettes, there are several plasmid templates that
can be used for PCR-based amplification of the linear PCR
fragments to be used as substrates for recombineering [e.g.,
pKD3 and pKD4 plasmids (Datsenko and Wanner, 2000)
containing FRT sites flanking either a chloramphenicol or
a kanamycin resistance cassette, respectively]. Routinely, to
prevent the generation of false positives, PCR products are
treated with DpnI restriction enzyme, which selectively digests
methylated parental DNA templates, or alternatively, when
selection markers are chromosomally located, colony-PCR can be
used for obtaining such linear PCR-fragments. Furthermore, the
conditional replication origins of the commonly used plasmids
averts plasmid persistence in case of incomplete DpnI digestion.
Upon FLP-mediated excision of such antibiotic resistance
cassettes (from pKD3 or pKD4), a sequence of ∼85 bp, generally
referred to as a scar sequence, remains in the chromosome.
To avoid undesired effects on expression of downstream genes,
the scar sequence contains stop codons in all the six reading
frames, a ribosome binding site (RBS), and a start codon for
downstream translation in polycistronic transcription units. This
scar may vary in length dependent on the template plasmid
chosen, with the minimal scar size reported being 36 bp
(Senecoff et al., 1988). In case of the pCP20 helper plasmid,
the FLP gene is expressed from the λ pR promoter under
the control of cI857 (Cox, 1983), and has a thermosensitive
replication origin to facilitate its cure upon FLP-mediated
excision (Cherepanov and Wackernagel, 1995).
A major limitation of this strategy arises when targeting
multiple genes due to possible recombination between existing
and incoming FRT sequences, or the occurrence of in cis
recombination between FRT scars. To overcome this situation,
a similar system consisting of the bacteriophage P1 Cre/loxP
has been used to excise selection markers (Nagy, 2000). Unlike
FRT sites, variants of loxP sites (e.g., loxLE, lox2272) can
be used when multiple gene targeting is needed. While still
being recognized by the Cre recombinase, the simultaneous
presence of multiple variant loxP sites in the genome will
remain, without the occurrence of undesired recombination
events (Carter and Delneri, 2010).
Following the original Datsenko protocol (Datsenko and
Wanner, 2000), single gene modification and subsequent
antibiotic cassette removal takes ∼7 days, considering the
sequential introduction and subsequent removal of temperature
sensitive helper plasmids, pKD46 and pCP20. However, by
merging both set of genes required for recombination and
selection marker excision into a single helper plasmid, the time
was reduced to only 3 days by alleviating the need of multiple
curing and transformation steps (Song and Lee, 2013; Jensen
et al., 2015). This protocol was further shortened to complete
7 sequential gene knock-outs in only 7 days, including the
removal of antibiotics resistance cassettes (Jensen et al., 2015). To
achieve this, λ red and FLP genes together with their respective
promotors were cloned in the chromosome, which enabled the
recovery and growth at permissive temperatures (37◦C instead
of 30◦C) throughout the process. Furthermore, FLP induction
times were shortened from overnight (∼18 h) to only 4 h, and the
use of two different resistance cassettes allowed the simultaneous
targeting of two genes.
OLIGO-MEDIATED
ALLELIC-REPLACEMENT (OMAR)
AVOIDS THE USE OF SELECTION
MARKERS
Instead of using PCR-generated dsDNA molecules containing
a selectable marker and flanking homology regions that reach
efficiencies of about 0.05%, synthetic short ssDNA oligos (50–
90 nt.) can also be used to generate small base substitutions
and insertions (up to ∼30 bp), as well as (larger) deletions
(up to ∼45 kbp). Even though the general scope is thus lower
compared to using dsDNA, the efficiency of OMAR outperforms
dsDNA-based recombineering reaching up to 25% of surviving
cells after electroporation when methyl-directed mismatch repair
system (MMR) is inactivated or bypassed (see below) (Costantino
and Court, 2003). Thus, the use of OMAR eliminates the
need for selection as only a manageable number of colonies
have to be tested for finding successful recombinants. Further,
the use of ssDNA substrates for λ red recombineering only
requires Bet for recombination, which delivers ssDNA oligos to
the replication fork where they anneal with the lagging strand
template (Costantino and Court, 2003).
Ellis et al. (2001) implemented the use of ssDNA for the
first time for correcting an amber mutation in galK which
generated a premature stop codon (Gal− phenotype). Cells were
selected for restoration of the Gal+ phenotype, obtaining 0.1%
recombination efficiency (Figure 1) when making use of 70
bases long ssDNA. When using 40–60 bases long ssDNA, this
efficiency dropped ∼5-fold, and with 30 bases long ssDNA
another ∼10-fold, until reaching background levels when using
20 bases long ssDNA (Ellis et al., 2001). Consistent with in vitro
experiments showing that Bet binds weakly to sequences shorter
than 36 bases (Mythili et al., 1996), decreasing the oligo length
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below 40 bases showed an exponential decrease in recombination
efficiency (Sawitzke et al., 2011). Increasing the length to 90–
120 bases however, showed only a ∼2 fold higher overall
efficiency (Wang et al., 2009), a very modest increase when
considering the significantly higher synthesis and purification
cost of longer oligos, as well as the increased probability of
introducing sequence errors during oligo synthesis.
Several host proteins act at the replication fork to prevent
the introduction of replication errors. One of the main
molecular repair systems at work is MMR that recognizes and
eliminates mismatches (Hsieh, 2001). Introducing defects in
this system proved to enhance the efficiency of oligo-mediated
recombineering over 100-fold (Costantino and Court, 2003;
Wang et al., 2009). Nonetheless, MMR perturbation leads to
an accumulation of undesired secondary mutations. To avoid
the use of such a background, the use of chemically modified
bases (e.g., 2’-fluoro-deoxyuridine, 5-methyl-deoxycytidine, 2,6-
diaminopurine or iso-deoxyguanosine), in synthetic oligos
proved to lower the occurrence of mismatch detection and
repair by MMR, thus improving the efficiency of OMAR up to
20-fold when compared to oligos with standard bases (Wang
et al., 2011). Another way to evade MMR is by improving
the design of mutating oligos (Sawitzke et al., 2011). Several
parameters showed to improve the frequency of oligo-mediated
recombination: incorporation of C/C mismatches (a mismatch
not recognized by many MMR systems) near a desired base
change, or substitution of four or more consecutive bases,
since MMR does not recognize multiple mispairs. Nevertheless,
introduction of additional changes is not always feasible or
desirable as it can alter gene or protein function. Alteration
of four or more wobble positions of adjacent codons could
help improve oligo recombineering efficiency without altering
the protein sequence, though altered mRNA stability and/or
protein expression might still come into play (Sawitzke et al.,
2011). Recently, the use of dominant-negative mutator alleles
of conserved DNA MMR proteins (e.g., MutS and MutL) was
implemented in genome engineering. Importantly, controlled
expression of a mutator allele aided the transient inhibition of
MMR in trans only during the recombination process and allows
recombineering and efficient OMAR in wild type cells (Nyerges
et al., 2016; Bubnov et al., 2018).
Other host recombination functions have generally no effect in
OMAR, except when limiting concentrations of oligos are used
(∼30 molecules/cell). In this case, significant single-stranded
exonuclease-mediated degradation of oligos has been observed,
thus affecting the frequency of recombination (Sawitzke et al.,
2011). However, recombination frequencies also decreased when
modifications were introduced within the last 9 nt. of the 5′
or 3′- oligo end (Sawitzke et al., 2011), providing additional
evidence of the occurrence of nuclease degradation at the
replication fork, even when making use of an optimal oligo
concentration. Another way to prevent oligo degradation by
endogenous endonucleases is by protecting the terminal bases
with phosphorothioate bonds (Wu et al., 2005). The allelic
replacement efficiency increased up to 2-fold when protecting
the 5’-oligo end by phosphorothioate bonds (Wang et al., 2009).
Of note, although at lower but still detectable frequency of
recombination [1 × 10−4 recombinants per viable cell (Swingle
et al., 2010b)], the use of ssDNA oligos in the absence of any phage
encoded functions attained targeted chromosomal modifications
in Escherichia coli, Pseudomonas syringae, S. enterica, Shigella
flexneri (Swingle et al., 2010b), Shewanella oneidensis (Corts et al.,
2019) and Legionella pneumophila (Bryan and Swanson, 2011).
RECOMBINEERING-INTRODUCED
GENETIC MUTATIONS RESULTING IN
POLAR EFFECTS
Genes encoding open reading frames (ORFs) are first transcribed
to messenger RNA (mRNA), which is either polycistronic,
encoding two or more proteins, or monocistronic, encoding
a single protein. In bacteria and archaea, polycistronic mRNA
transcripts frequently encode functionally related proteins.
A transcriptome study in S. enterica found approximately 60%
of studied genes to be expressed from polycistronic mRNA
transcripts (Ramachandran et al., 2014). In fact, bacterial operons
were reported to have an average of 1.4–2.1 genes per operon
(Yan et al., 2018). Therefore, the polycistronic nature of bacterial
mRNA transcripts makes single gene targeting challenging,
mainly because of possible perturbations of downstream or
upstream gene expression at the transcriptional and/or the
translational level. Upon gene targeting, transcription of the
introduced selectable marker (e.g., antibiotic resistance cassette)
can affect the expression of downstream genes. Even after
removal of such a marker, the presence of the resulting scar,
although typically restricted in size, could alter gene expression
due to the removal or change of regulatory sequences.
To circumvent this problem when constructing gene knock-
outs, homology regions have been designed in such a manner to
generate single in-frame deletions. The Keio collection of 3985
gene knock-outs in E. coli was created this way to minimize
effects of the deletions on the expression of downstream or
upstream genes, referred to as polar effects (Baba et al., 2006).
This strategy consisted of leaving the sequence encoding the
last 7 codons of the ORF targeted for deletion intact, thereby
leaving the stop codon and possible RBSs of downstream genes
in their normal chromosome context. For instance, deletion
of the hplA gene, encoding a periplasmatic chaperone for
outer membrane proteins, was successfully achieved by this in-
frame scar approach. This hinted that the previously presumed
essentiality of the hplA gene was incorrectly inferred because of
a polar effect on expression of the downstream essential gene
lpxD. During the construction of a similar library in S. enterica
(Porwollik et al., 2014), in-frame deletions were generated leaving
the last 5 codons at the 5′- and 3′-ends of the ORFs targeted
for deletions intact. Moreover, for the purpose of monitoring
polar effects due to the presence of the promoter of the antibiotic
resistance markers, kanamycin and chloramphenicol resistance
cassettes were used to target the same gene in both sense and
anti-sense translation direction, respectively, Porwollik et al.
(2014). Normally, when referring to polar effects, downstream
gene effects are discussed since these occur far more frequently
due to the direction of transcription. To more precisely avoid
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polar effects introduced by the presence of selection marker genes
or residual scar sequences, the implementation of alternative
strategies is clearly needed. Alternative approaches to avoid such
polar effects are presented in the next section.
SEAMLESS RECOMBINEERING AND
SCARLESS REMOVAL OF SELECTION
MARKERS
Scarless genome editing aims to obtain recombinants devoid of
scar sequences. Many of these approaches are based on the use
of homing endonucleases, such as I-SceI from Saccharomyces
cerevisiae. This endonuclease recognizes and cuts an unusually
long 18 bp sequence, ensuring a recognition site-specific cleavage.
The introduction of an I-SceI recognition sequence in the target
region, followed by expression of I-SceI endonuclease from a
helper plasmid generates a double strand break (DSB) in the
chromosome. This way, either the bacteria cannot survive, or
the DSB is fixed by recombination with a sister chromosome,
or a provided template. As described below, DSB-induced
recombination can involve intra- (in cis) or extrachromosomal
(in trans) recombination (Figure 4). Noteworthy, in case of
active transcription and transcription continuation into the
inserted mutation cassette, cleavage at the I-SceI site might
not be efficient. To overcome this, two successive transcription
terminator sequences are often introduced just before the I-SceI
specific recognition site (Kim et al., 2014).
DSB-induced in cis recombination was first introduced
by Posfai et al. (1999) who used a suicide plasmid strategy
encoding a mutant copy of the target gene to be introduced
in the chromosome, containing both an antibiotic resistance
cassette and the I-SceI recognition site (Figure 4A). DSB-
induced recombination between direct repeats (wild-type
and mutant target gene) was initiated by expressing I-SceI
endonuclease from a helper plasmid. Transformants obtained
by in cis recombination can contain either a copy of the
wild-type or mutant gene. In the absence of a DSB, the
spontaneous frequency of recombination was calculated to
be ∼2 × 10−3/generation; with the introduction of a DSB,
recombination efficiency increased by 2–3 orders of magnitude
(Posfai et al., 1999; Figure 1).
After using a suicide vector, screening for transformants
containing the desired mutation is needed. An alternative
to the use of suicide plasmids to deliver in cis homologous
regions is the use of linear DNA in strains expressing λ red
recombination genes. In this way, deletions up to 117 kbp
were generated (Figure 4B; Yu et al., 2008). The linear DNA
fragment contains 3 homology regions to the chromosome:
H1 and H3 have homology to the upstream and downstream
regions targeted for deletion, and H2 has homology to the 3′-
end of the region targeted for deletion. The linear fragment
is introduced in the chromosome by λ red-mediated dsDNA
recombination with ∼50 bp homology regions H1 and H2.
This step is followed by the introduction of a DSB site
within the insertion, allowing for recombination between the
duplicated H3 sequences (∼500 bp each). An improvement of
this approach uses H3 homology regions with a length of∼75 bp
to perform deletions, shortening the linear fragment length
required (Figure 4B; Tas et al., 2015). Moreover, to promote
cleavage and elimination of the helper plasmid encoding the
λ red recombination genes, an I-SceI recognition site can be
incorporated in this plasmid, concomitantly allowing assessment
of I-SceI endonuclease cutting efficiency (Lee et al., 2009).
DSB-induced recombination with in trans substrates
(Figure 4B) requires the construction of an intermediate strain.
This is achieved by λ red recombination of a first PCR fragment
(PCR-1) introducing the I-SceI recognition site and an antibiotic
resistance cassette into the target region of the chromosome
(Figure 4B; Cox et al., 2007). Once the intermediate strain
is generated, a second PCR product (PCR-2) is introduced
together with a helper plasmid for expression of the I-SceI
endonuclease. PCR-2 contains the same homologous flanking
sites as PCR-1 and the desired sequence to be inserted, or solely
the homologous flanking sites, when a deletion is desired. Only
cells where the DSB is repaired by recombination with PCR-2
can survive. The landing pad (LP) strategy (Tas et al., 2015)
uses galK and tetA genes flanked by I-SceI recognition sites to
select for the intermediate strain generated and to counter-select
DSB-induced recombination and consequent loss of the marker.
Large fragment insertions (6.5 kbp) were achieved in the second
recombination step with efficiencies ∼75–97% depending on
the target site. Moreover, OMAR-assisted LP replacement was
used to delete 6 kbp with an efficiency of 60% for lagging oligos,
but only 10% for leading oligos (Tas et al., 2015). A variant of
the LP technique delivers the LP construct in a plasmid instead
of a linear construct to avoid the use of electroporation (Wei
et al., 2017). In this study, an alternative endonuclease from
Chlamydomonas reinhardtii, I-CreI, was used to catalyze the
in vivo excision of the LP from the plasmid. Similar to the
extended 18 bp I-SceI recognition sites, I-CreI recognition sites
are 22 bp in length.
Another scarless approach termed gene gorging (Herring
et al., 2003) claims to avoid the use of selection markers
as the replacement occurs in 1–15% of transformed cells
(Figure 1), and this way, the direct screening for mutants
containing deletions is in principle permitted. Here, instead
of transforming cells with linear DNA, the recombineering
template is delivered as a plasmid and co-transformed with
another helper plasmid encoding arabinose-inducible λ red
recombination genes and I-SceI endonuclease. Upon selection
of co-transformants, colonies are grown in media containing
arabinose and the linear fragment is generated and integrated
in the chromosome by I-SceI endonuclease restriction and λ
red recombineering, respectively. A similar scarless approach
(Gerlach et al., 2009) to the one described in Figure 4B, used
the insertion of the tetA and tetR genes providing tetracycline
resistance, followed by λ red recombination with ∼80 bp
complementary oligos in the absence of a I-SceI cleavage step.
The oligos were annealed to form dsDNA before electroporation
and then, depending on how the flanking homology sites
were chosen, an in-frame deletion or site-directed mutagenesis
was achieved. When using I-SceI DSB-induced recombination,
96% of the tested clones contained the correct modification
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FIGURE 4 | Scarless genome editing by intra- (in cis) or extrachromosomal (in trans) recombination. (A) DSB-induced in cis recombination by I-SceI endonuclease,
with a mutated version of the target region inserted into the chromosome by a conditional replicating suicide plasmid (left) or with an identical sequence inserted into
the chromosome by λ red recombination with a linear dsDNA fragment (right). (B) DSB-induced in trans recombination by I-SceI endonuclease, comprising the initial
generation of an intermediate strain by introduction of landing pad (LP) counter-selection cassette (PCR-1) by λ red recombination. Subsequent introduction of
editing substrates (PCR-2) into the intermediate strain and expression of I-SceI endonuclease stimulates excision of the LP and repair of the DSB by recombination
with editing substrates, overall resulting in transformants with an insertion (left) and a deletion (right). H1-H3, homology regions 1-3; DSB, double strand break; LP,
landing pad.
(Cox et al., 2007), while leaving I-SceI out resulted in 80–90%
correct clones in case of site-directed mutagenesis, but only 33%
of correct deletions (Figure 1).
CRISPR-CAS GENE TARGETING ASSIST
BACTERIAL RECOMBINEERING
The successful implementation of selection-free recombineering
strategies depends on their editing efficiencies, which can
be achieved by increasing the frequency of chromosomal
modification to an extent where edited cells represent a
significant number of colonies in the outgrowth plate. Another
way of increasing the percentage of edited cells in the
outgrowth plate is by simply eliminating non-edited cells.
In this way, the recently identified prokaryote adaptive
immune CRISPR-Cas9 (clustered regularly interspaced short
palindromic repeats and its associated protein, Cas9) system
can assists bacterial recombineering as the specificity of
sequence-specific nucleases can be programmed by small
RNA molecules (Barrangou et al., 2007; Jinek et al., 2012).
Following identification of these enzymes, CRISPR-Cas nucleases
have been broadly used as a genome editing tool in a
variety of organisms including bacteria (Feng et al., 2013;
Jiang et al., 2013; Wang et al., 2013; Nayak and Metcalf,
2017). CRISPR-Cas nucleases are dsDNA endonucleases that
are directed by single guide RNA (sgRNA) to perform
sequence-specific cleavages. sgRNA target sequences are termed
protospacers, and their cleavage by CRISPR/Cas nucleases
essentially requires a triplet sequence downstream of the
protospacer termed protospacers-adjacent motifs (PAM), e.g.,
NGG for Cas9 nuclease from Streptococcus pyogens. This
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requirement does not represent a major limitation for gene
editing with S. pyrogens Cas9 in E. coli, as greater than
400,000 GG doublets are present in the E. coli genome
(Keseler et al., 2013). To target Cas9 to protospacers, sgRNA
is typically encoded in a CRISPR array consisting of short
repeated sequences separated by unique spacers that upon
processing generates CRISPR RNA (crRNA) to be loaded in
Cas9 in a process dependent of a trans-activating crRNA
(tracrRNA) and RNAseIII. Specific design of crRNA sequences
enables gene-specific Cas9 endonuclease targeting and dsDNA
cleavage (Barrangou, 2012), overall making CRISPR very useful
for recombineering by specifically targeting non-recombinants
(Barrangou et al., 2007; Jinek et al., 2012).
Jiang and coworkers adapted Cas9 selection for genome
editing in bacteria (Jiang et al., 2013). More specifically, Cas9
was constitutively expressed in HME63, a recombineering
efficient E. coli strain expressing the λ red bet gene from
the chromosome (Costantino and Court, 2003). A two-plasmid
system, pCas9 and pCRISPR, encoding Cas9 and carrying the
array of CRISPR spacers, respectively, was used to achieve
ssDNA oligo assisted point mutagenesis of rpsL with an editing
oligo. Co-electroporation of the editing oligo with the pCRISPR
plasmid containing CRISPR array with crRNA sequences guided
Cas9 cleavage of the wild-type but not the mutant rpsL gene
(Figure 5). The efficiency of OMAR was increased from ∼0.005
to ∼65% when combined with Cas9 targeting of non-modified
chromosomes to eliminate non-edited bacteria (Jiang et al.,
2013). Since then, other studies reported on the combined use
of Cas9 selection and recombineering in E. coli. A three-plasmid
system approach in the E. coli DH5α strain, reported the use
of pCas9 and pCRISPR plasmids (Jiang et al., 2013), as well as
pKD46 to deliver λ red recombination genes in trans (Pyne et al.,
2015). Besides single point mutagenesis, other modifications
such as large deletions (up to ∼19.4 Kbp) were achieved by
combining recombineering using dsDNA editing substrates with
Cas9 selection, generally achieving efficiencies ranging from few
percentages to about 50% of the colonies following outgrowth.
Once successful genome engineering is achieved, the curing of
the original helper plasmids is desired, particularly when multiple
chromosomal manipulations are performed in the same strain.
For example, a plasmid carrying sgRNA sequences, the λ red
genes and a conditional replicating origin can be cured at non-
permissive temperatures of 37◦C (Reisch and Prather, 2017).
Moreover, plasmid pCas9cr4 elimination was effectively achieved
by p15A ori Cas9-directed cleavage, by delivering pKDsg-p15A
(Reisch and Prather, 2017). Another nuclease, CRISPR-Cas12a,
was also successfully coupled to recombineering in E. coli, as
comparable efficiencies to those reported for Cas9 were observed
when attempting to perform site-directed mutagenesis of lacZ
or gene specific deletions (∼1000 bp). Although to obtain
high efficiencies, and despite co-expression of the Gam, Exo
and Bet proteins, efficient insertion with this system required
recombineering substrates with 500 bp flanking homologies
(Yan et al., 2017).
Taken together, CRISPR-Cas specific gene targeting enhances
the efficiency of recombineering, making it a preferred strategy
for introducing multiple genome edits as it does not require
recycling of selection markers (Jiang et al., 2015; Ronda
et al., 2016). The main inconvenience of these strategies is
incompleteness of Cas9 targeting of wild-type non-edited cells,
referred to as escapers, resulting in an increased background of
non-edited cells on the outgrowth plate. A recent study based on
the oligo-assisted point mutagenesis of rpsL coupled to CRISPR-
Cas9 (Cui and Bikard, 2016) showed that E. coli can survive Cas9
cleavage at certain targets by triggering the SOS response, which
results in repair of the dsDNA break with a sister chromosome
by homologous recombination. To improve efficiency of Cas9
targeting of non-edited cells, the Gam protein from phage Mu
known to block DNA repair was expressed (Shee et al., 2013).
Escapers can also result from spontaneous mutations in crRNA,
PAM or protospacer sequences, preventing sequence-specific
CRISPR-Cas9 nuclease targeting (Jiang et al., 2013).
Since recombineering coupled to CRISPR-Cas strategies was
only implemented in recent years, protocols have typically been
developed in strain-specific manners and optimized for a single
or few target(s) (Jiang et al., 2015; Ronda et al., 2016). A robust
method widely applicable to different chromosomal targets is
limited by the broad variation in the on-target activity of sgRNAs
observed (Guo et al., 2018). To overcome this, a comprehensive
library analyzing 70,000 sgRNAs targeting different regions in
the E. coli chromosome distinguished highly active sgRNA
sequences from “protected” genome sites with weak sequence-
specific CRISPR-Cas9 specificity. From this extensive map, a tool
to design optimal sgRNA sequences was developed to facilitate
further assistance of CRISPR-Cas9 in recombineering (Guo et al.,
2018). Nevertheless, further efforts to elucidate chromosomal
features and mechanisms “protecting” specific targets are needed
to optimize CRISPR-Cas9 specificity and to obtain similar
efficiencies over the whole chromosome. Finally, other drawbacks
in the implementation of CRISPR-Cas9 assisted recombineering
such as Cas9 cytotoxicity are discussed in Vento et al. (2019).
λ RED-BASED RECOMBINEERING IN
OTHER BACTERIAL SPECIES
While inherently, non-transformable bacteria cannot be
subjected to recombineering, adapting this approach to
transformable non-E.coli hosts is still challenging as λ red and
Rac recombineering functions do not display the same efficiency
across bacteria. Besides manipulation of the RecA-RecBCD
dependent recombination pathways as a useful alternative in
case of λ red incompatibility, better success for recombineering
of non-E. coli bacteria has been to employ bacteria-specific phage
homologous recombination systems (van Kessel and Hatfull,
2007, 2008; Swingle et al., 2010a; Yin et al., 2015, 2017, 2019; Lee
et al., 2017; Murphy et al., 2018; Corts et al., 2019). For example,
inducible expression of the distantly related RecE and RecT
mycobacteriophage Che9c gp60 and gp61 genes catalyzed the
deletion of different genes in M. smegmatis and M. tuberculosis,
using dsDNA substrates with ∼500 bp flanking homologies
(van Kessel and Hatfull, 2007). Later, Che9c gp61 was shown to
promote ssDNA recombineering using homologies as short as
50 nt oligos (van Kessel and Hatfull, 2008). In a recent study,
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FIGURE 5 | CRISPR-Cas9 based bacterial recombineering. Site-directed mutagenesis of the rplL gene by use of an editing oligo in the HME63 strain and an
inducible plasmid encoding PCas9 and λ red genes. Co-transformation of the editing oligo with the pCRISPR:rpsL plasmid, the latter harboring the crRNA sequence
directs Cas9 endonuclease targeting of non-edited cells. Figure adapted from “RNA-guided editing of bacterial genomes using CRISPR-Cas systems”
(Jiang et al., 2013).
gp61-based oligo recombineering was used to introduce an attP
site into the chromosome target site. Simultaneous co-expression
of the phage Bxb1 integrase induced site-specific recombination
between attP and attB sites, the latter being delivered on a non-
replicating plasmid with an antibiotic selection marker attaining
insertion and gene editing (Murphy et al., 2018). This ingenious
workaround approach termed oligonucleotide-mediated
recombineering followed by Bxb1 integrase targeting (ORBIT)
overcomes the use of lengthy flanking homologies needed when
using dsDNA editing substrates. Following deletion formation,
curing of the drug marker by plasmid excision is achieved by
expressing the phage Bxb1 site-specific excision system, which
includes both the phage integrase and directionality factor gp47.
Nevertheless, ORBIT leaves the antibiotic resistance markers
or an attP site (48 bases) in case of insertions and deletions,
respectively, Murphy et al. (2018).
Another example of the utility of an endogenous phage
recombination system in a non-E. coli bacteria is the use of
W3 Beta recombinase from a Shewanella oneidensis prophage,
a homolog of λ red Beta sharing 55% identity. This protein
catalyzes recombination with ssDNA oligos containing 40 nt
homology arms, and was also functional in E. coli with similar
efficiencies as compared to λ red Beta (Corts et al., 2019).
The use of recombinase proteins encoded in the SXT mobile
genetic element was also reported in the marine bacterium
Vibrio natriegens. Here SXT-Beta and SXT-Exo share 43.6 and
21.5% identity with their λ- homologs, respectively. Even though
SXT-Beta catalyzed recombination reactions with 90 nt ssDNA
oligos, recombination with dsDNA editing templates (flanked
by long-homology arms of 500 bp) requires the additional
expression of SXT-Exo and λ-Gam, as no homolog of the later
protein was identified (Lee et al., 2017).
The Plu2934, Plu2935, and Plu2936 phage proteins encoded
by the red-like operon Pluγβα (functional analogs of Redγ,
Redβ en Redα) was shown to be effective in Photorhabdus
luminescens. While Plu2934 (or Plu-Gam) was functional
in E. coli, λ-Gam was not active in P. luminescens and
Plu2934 recombination efficiencies obtained were higher in its
endogenous host P. luminescens than in E. coli (Yin et al., 2015,
2017). The implementation of Plu-Gam protein was further
tested in Pseudomonas strains aiming to establish a broadly
applicable recombineering protocol in this large genus (Yin
et al., 2019). More specifically, Plu-Gam, and λ-Gam improved
the recombineering efficiency of RecTEPsy, a RecET-like operon
from Pseudomonas syringae (Swingle et al., 2010a), as well as
the λ-red-like BAS operon from Pseudomonas aeruginosa phage
Ab31 (Yin et al., 2019) in P. aeruginosa and P. fluorescens,
but not in P. putida or P. syringae. Of note, while λ red
and Plu operons were inefficient to promote recombineering
in Pseudomonas, the BAS operon was functional in all of the
Pseudomonas strains mentioned above. Interestingly, in addition
to the orf38 (or B) and orf37 (or A) homologs of λ red bet
and exo, respectively, the AS operon contains orf36 (or S), a
ssDNA binding (SSB) protein that was shown to improve the
recombination efficiency of BA and RecET in E. coli, but not λ
red functions (Yin et al., 2019).
These studies clearly indicate the dependence of phage
recombineering functions on host-specific machinery (Datta
et al., 2008), in line with reported observations on similar
efficiencies of λ red recombineering in related bacteria such
as S. enterica (Stanley et al., 2000; Czarniak and Hensel,
2015), Shigella flexneri (Shi et al., 2003; Wang Y. et al., 2014),
Klebsiella pneumoniae (Wei et al., 2012; Guo et al., 2013),
Yersinia enterocolitica (Trulzsch et al., 2004), Yersinia pestis
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(Sun et al., 2008), and Zymomonas mobilis (Khandelwal et al.,
2018). In these studies, λ red recombineering genes were
expressed from pKD46 (Datsenko and Wanner, 2000) or pSIM
(Datta et al., 2006) plasmids, from PBAD or PL promoters,
respectively. In particular, attempts to use pKD46 in Escherichia
albertii were unsuccessful, while pSIM λ-red expression was
effective for achieving chromosomal mutations (Egan et al.,
2016), an observation presumably due the higher levels of
expression of the λ red genes when expressed from pSIM, when
compared to pKD46 (Datta et al., 2006). Noteworthy, in these
bacteria, the lengths of flanking homologies were similar to those
reported for E. coli. For completeness we also refer to Murphy
(2016), where more examples on transferring the recombinogenic
potential of λ red genes to other bacteria are discussed.
In addition to phage origin, expression of phage
recombineering functions often require host compatible
plasmid systems. A representative example of this is the use
of λ red recombineering expression system in Agrobacterium
tumefaciens. More specifically, the arabinose inducible promoters
(i.e., pBAD) commonly used for λ red genes expression, could
not be implemented in Agrobacterium tumefaciens as this
promoter did not work well in this bacterial context; as such,
a tetracycline inducible promoter was used instead (Hu et al.,
2014). While an initial study in Pseudomonas aeruginosa
reported on the requirement of long homology flanking regions
of 400-600 bp when expressing λ red recombineering genes
(Lesic and Rahme, 2008), expression of λ red recombineering
genes from another plasmid, pRKaraRed (Liang and Liu, 2010)
(with oriV and trfA regions to support plasmid replication and
stability in P. aeruginosa) showed homology flanking region
requirements of only 50 bp. In some cases, the expression of
λ red recombineering genes was proven to be toxic, as shown
for the enterobacteriaceae Pantoea ananatis (Katashkina et al.,
2009), requiring the use of mutant strains to express λ red genes
(Katashkina et al., 2009). Adaptation of Rac recombineering was
proven successful in case of Zymomonas mobilis (Wu et al., 2017),
Acinetobacter baumannii (Tucker et al., 2019), Corynebacterium
glutamicum (Huang et al., 2017) and Pseudomonas putida (Choi
and Lee, 2020) among others.
CONCLUSION
Reverse genetic approaches to decipher gene function have
significantly improved over the years with the development
of highly efficient recombineering approaches. In this way,
the realization of successful transformants was significantly
improved as it merely required a one-step electroporation
protocol of simple PCR products or synthetic oligos.
Furthermore, prior subcloning of the mutant allele containing
the desired genetic modification in appropriate vectors (i.e.,
suicide vectors) was circumvented. Selection of a suitable
recombineering strategy depends on the intended modification.
For instance, when aiming to insert DNA sequences, the size
of the insert must be considered to choose the proper editing
substrate. In particular, short insertions can be achieved by
ssDNA oligos [up to 60 bp – see Murphy et al. (2018)], while
the introduction of longer sequences, in cases of gene tagging
or reporter fusions, required dsDNA recombineering substrates.
Besides this limitation, OMAR approaches obtain a higher
efficiency than dsDNA recombination and are scarless, as they
avoid the use of selection markers; oligo recombineering is
also mechanistically better understood. On the other hand,
the development of scarless approaches based on eliminating
non-edited background by specific endonucleases (e.g., I-SceI),
or more recently, the use of CRISPR directed Cas9 endonuclease,
increased the percentage of positive transformants to the point
where, as in OMAR approaches, the use of selection markers
is often not mandatory (Figure 1), making these approaches
preferable over those relying on (counter) selection of introduced
markers. In contrast to the use of other specific endonucleases
(e.g., I-SceI) for the elimination of non-edited background, the
use of CRISPR-Cas endonucleases do not require the a priori
introduction of specific recognition sequences for cleavage
(e.g., the I-SceI recognition sequence). The implementation
of CRISPR-Cas endonucleases however remains critical due
to the outgrowth of wild-type survivors, also termed escapers.
Furthermore, reported frequencies of escapers vary greatly
dependent on the target gene, hinting that future research
efforts need to focus on elucidating the molecular basis of these
findings as to increase the robustness and wider applicability
of CRISPR-Cas selection in assisting recombineering. Finally,
while recombineering strategies described in this review mainly
provide an overview of currently existing strategies to attain
different genetic engineering in E. coli and S. enterica for reverse
genetics studies, λ red recombineering and RecET phage proteins
are not always as efficient or even operational as their usage
failed in many distantly related Escherichia coli strains. As such,
future recombineering efforts may help to overcome remaining
pitfalls and drawbacks and extend the use of recombineering
to other bacteria.
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